Development of an Innovative Modular System for Continuous Chemical Processing

开发连续化学处理的创新模块化系统

• 批准号: 101325
• 金额: $ 52.35万
• 依托单位: BLACK TRACE HOLDINGS LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2013
• 资助国家: 英国
• 起止时间: 2013 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=101325
• 关键词: Development; Innovative; Modular; System; Continuous

The project, lead by Syrris, in collaboration with GSK, AMRI UK and the EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation will develop an innovative modular system for continuous chemical processing. It will develop modules that can be used by any chemical industry to perform unit operations such as liquid-liquid, liquid-solid and liquid-solid-gas phase reactions, crystallisations and aqueous work-up in a continuous process, with analysis. The modules will be scalable, easy to use, automatable and able to be quickly reconfigured into hundreds of conceivable single or multi step process systems. Within the project lifetime, this will enable GSK and AMRI to operate more efficient, high quality and sustainable processes with easier scale-up. After the project, commercialisation of these modules will enable the wider chemical process industry to benefit from the same advantages and generate significant exports for the UK.

该项目由syris牵头，与GSK、AMRI UK和EPSRC连续制造和结晶创新制造中心合作，将开发一种用于连续化学处理的创新模块化系统。它将开发可用于任何化学工业的模块，以执行单元操作，如液-液、液-固、液-固-气相反应、结晶和水处理等连续过程，并进行分析。这些模块将是可扩展的，易于使用，自动化的，能够快速重新配置成数百个可想象的单步或多步过程系统。在项目生命周期内，这将使GSK和AMRI能够更高效、高质量和可持续的流程，并更容易扩大规模。项目结束后，这些模块的商业化将使更广泛的化学加工工业受益于同样的优势，并为英国带来可观的出口。